Izraēla - ivrits - Ministry of Health

novartis pharma services ag - clozapine 25 mg - tablets - clozapine - treatment of resistant schizophrenic patients who are non-responsive to, or intolerant of classic neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for death.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.

Izraēla - ivrits - Ministry of Health

novartis pharma services ag - clozapine 100 mg - tablets - diazepines, oxazepines, thiazepines and oxepines - for treatment in resistant schizoprenic patients who are non-responsive to, or intolerant to classical neuroleptics. reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state. suicidal behavior refers to actions by a patient that put him/herself at risk for diath.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - baclofen - טבליה - baclofen 25 mg - other centrally acting agents - muscle spasticity of various origins.

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glycopyrronium as bromide - אבקה לשאיפה בקפסולות קשיחות - glycopyrronium as bromide 50 mcg - glycopyrronium

Izraēla - ivrits - Ministry of Health

novartis israel ltd - ribociclib as succinate - טבליות מצופות פילם - ribociclib as succinate 200 mg - ribociclib

Izraēla - ivrits - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 0.25 mg - siponimod

Izraēla - ivrits - Ministry of Health

novartis israel ltd - siponimod as fumaric acid - טבליות מצופות פילם - siponimod as fumaric acid 2 mg - siponimod

Izraēla - ivrits - Ministry of Health

novartis israel ltd - glycopyrronium as bromide; indacaterol as acetate; mometasone furoate - קפסולה קשיחה - mometasone furoate 160 mcg; glycopyrronium as bromide 50 mcg; indacaterol as acetate 150 mcg - mometasone